Chapter 1: Executive summary 1.1 Market scope and segmentation 1.2 Key questions answered in this study 1.3 Executive summary - I 1.4 Executive summary – II Chapter 2: Market overview 2.1. Market definitions 2.2. Global market overview – by revenue - Global historical (2015-2017) market revenue (USD Bn) - Global forecasted (2018-2023) market revenue (USD Bn) - Geography-wise market (2018-2023) revenue (USD Bn) 2.3. Global market overview – by volume - Global historical (2015-2017) market volume (Million units) - Global forecasted (2018-2023) market volume (Million units) - Geography-wise (2018-2023) market volume (Million units) 2.4. Global market drivers and challenges 2.4.1. Global market drivers 2.4.2. Global market challenges 2.5. Global market trends 2.6. Value chain 2.7.1. Regional market overview - North America - Observation - Key competitors 2.7.1(A) Regional market overview – North America by revenue and by volume - North America historical (2015-2017) market revenue (USD Bn) - North America forecasted (2018-2023) market revenue (USD Bn) - North America historical (2015-2017) market volume (Million units) - North America forecasted (2018-2023) market volume (Million units) 2.7.2. Regional market overview – Europe - Observation - Key competitors 2.7.2(A) Regional market overview – Europe by revenue and by volume - Europe historical (2015-2017) market revenue (USD Bn) - Europe forecasted (2018-2023) market revenue (USD Bn) - Europe historical (2015-2017) market volume (Million units) - Europe forecasted (2018-2023) market volume (Million units) 2.7.3. Regional market overview – Asia-Pacific - Observation - Key competitors 2.7.3(A) Regional market overview – Asia Pacific by revenue and by volume - Asia Pacific historical (2015-2017) market revenue (USD Bn) - Asia Pacific forecasted (2018-2023) market revenue (USD Bn) - Asia Pacific historical (2015-2017) market volume (Million units) - Asia Pacific forecasted (2018-2023) market volume (Million units) 2.7.4. Regional market overview – Latin America - Observation - Key competitors 2.7.4(A) Regional Market Overview – Latin America by revenue and by volume - Latin America historical (2015-2017) market revenue (USD Bn) - Latin America forecasted (2018-2023) market revenue (USD Bn) - Latin America historical (2015-2017) market volume (Million units) - Latin America forecasted (2018-2023) market volume (Million units) 2.7.5. Regional market overview – Middle East & Africa - Observation - Key competitors 2.7.5(A) Regional market overview – Middle East & Africa by revenue and by volume - Middle East & Africa historical (2015-2017) market revenue (USD Bn) - Middle East & Africa forecasted (2018-2023) market revenue (USD Bn) - Middle East & Africa historical (2015-2017) market volume (Million units) - Middle East & Africa forecasted (2018-2023) market volume (Million units) Chapter 3: Major segment overview - global by disease indication 3.1. Disease indication: Pneumococcal, Hib - by revenue, by volume, CAGR - Overview - by disease indication - Market share (2015, 2018 & 2023): Pneumococcal – global revenue (USD Bn) - Market share (2015, 2018 & 2023): Pneumococcal – global volume (Million units) - Market share (2015, 2018 & 2023): Hib – global revenue (USD Bn) - Market share (2015, 2018 & 2023): Hib – global volume (Million units) 3.2. Disease indication: DTP, Meningococcal - by revenue, by volume, CAGR - Overview - by disease indication - Market share (2015, 2018 & 2023): DTP – global revenue (USD Bn) - Market share (2015, 2018 & 2023): DTP – global volume (Million units) - Market share (2015, 2018 & 2023): Meningococcal – global revenue (USD Bn) - Market share (2015, 2018 & 2023): Meningococcal – global volume (Million units) Chapter 4: Major segment overview - global by end user 4.1. End-user: Pediatric, Adult - by revenue, by volume, CAGR - Overview - by end user - Market share (2015, 2018 & 2023): Paediatric – global revenue (USD Bn) - Market share (2015, 2018 & 2023): Paediatric – global volume (Million units) - Market share (2015, 2018 & 2023): Adult – global revenue (USD Bn) - Market share (2015, 2018 & 2023): Adult – global volume (Million units) Chapter 5: North America – by disease indication 5.1. North America: disease indication - Pneumococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways 5.2. North America: disease indication - Haemophilus Influenza type b conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways 5.3. North America: disease indication - Diphtheria-Tetanus-Pertussis conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways 5.4. North America: disease indication - Meningococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways Chapter 6: North America – by end user 6.1. North America: end user - Pediatric & Adult conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Key takeaways Chapter 7: Europe – by disease indication 7.1. Europe: disease indication - Pneumococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways 7.2. Europe: disease indication – Haemophilus Influenza type b conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways 7.3. Europe: disease indication - Diphtheria-Tetanus-Pertussis conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways 7.4. Europe: disease indication - Meningococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways Chapter 8: Europe – by end user 8.1. Europe: end user - Pediatric & Adult conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Key takeaways Chapter 9: Asia Pacific – by disease indication 9.1. Asia Pacific: disease indication - Pneumococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways 9.2. Asia Pacific: disease indication – Haemophilus Influenza type b conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways 9.3. Asia Pacific: disease indication - Diphtheria-Tetanus-Pertussis conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways 9.4. Asia Pacific: disease indication - Meningococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways Chapter 10: Asia Pacific – by end user 10.1. Asia Pacific: end user - Pediatric & Adult conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Key takeaways Chapter 11: Latin America - by disease indication 11.1. Latin America: disease indication - Pneumococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways 11.2. Latin America: disease indication – Haemophilus Influenza type b conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways 11.3. Latin America: disease indication - Diphtheria-Tetanus-Pertussis conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways 11.4. Latin America: disease indication - Meningococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways Chapter 12: Latin America - by end user 12.1. Latin America: end user - Pediatric & Adult conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Key takeaways Chapter 13: Middle East & Africa - by disease indication 13.1. Middle East & Africa: disease indication - Pneumococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways 13.2. Middle East & Africa: disease indication – Haemophilus Influenza type b conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways 13.3. Middle East & Africa: disease indication - Diphtheria-Tetanus-Pertussis conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways 13.4. Middle East & Africa: disease indication - Meningococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways Chapter 14: Middle East & Africa - by end user 14.1. Middle East & Africa: end user - Pediatric & Adult conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways Chapter 15: Competitive landscape 15.1. Company market share - Top 5 companies 15.2. Company overview - GlaxoSmithKline - Company snapshot - Product offerings - Growth strategies - Initiatives - Geographical presence 15.2(A) Executive profile – GlaxoSmithKline 15.3. Company overview – Pfizer Inc. - Company snapshot - Product offerings - Growth strategies - Initiatives - Geographical presence 15.3(A) Executive profile - Pfizer Inc. 15.4. Company overview – Merck & Co. - Company snapshot - Product offerings - Growth strategies - Initiatives - Geographical presence 15.4(A) Executive profile - Merck & Co. 15.5. Company overview – Novartis - Company snapshot - Product offerings - Growth strategies - Initiatives - Geographical presence 15.5(A) Executive profile - Novartis 15.6. Company overview – Sanofi Pasteur - Company snapshot - Product offerings - Growth strategies - Initiatives - Geographical presence 15.6(A) Executive profile - Sanofi Pasteur 15.7. Company overview – CSL Limited - Company snapshot - Product offerings - Growth strategies - Initiatives - Geographical presence 15.7(A) Executive profile - CSL Limited 15.8. Company overview – Bharat Biotech International - Company snapshot - Product offerings - Growth strategies - Initiatives - Geographical presence 15.8(A) Executive profile - Bharat Biotech International 15.9. Company overview – Biological E Limited - Company snapshot - Product offerings - Growth strategies - Initiatives - Geographical presence 15.9(A) Executive profile - Biological E Limited 15.10. Company overview – Serum Institute of India - Company snapshot - Product offerings - Growth strategies - Initiatives - Geographical presence 15.10(A) Executive profile - Serum Institute of India Appendix - List of tables - Assumptions - Conclusion - Research and methodology - About Netscribes Inc.

Chapter 2: 1. Global historical (2015-2017) market revenue (USD Bn) 2. Global forecasted (2018-2023) market revenue (USD Bn) 3. Geography-wise (2018-2023) market revenue (USD Bn) 4. Global historical (2015-2017) market volume (Million units) 5. Global forecasted (2018-2023) market volume (Million units) 6. Geography-wise (2018-2023) market volume (Million units) 7. North America historical (2015-2017) market revenue (USD Bn) 8. North America forecasted (2018-2023) market revenue (USD Bn) 9. North America historical (2015-2017) market volume (Million units) 10. North America forecasted (2018-2023) market volume (Million units) 11. Europe historical (2015-2017) market revenue (USD Bn) 12. Europe forecasted (2018-2023) market revenue (USD Bn) 13. Europe historical (2015-2017) market volume (Million units) 14. Europe forecasted (2018-2023) market volume (Million units) 15. APAC historical (2015-2017) market revenue (USD Bn) 16. APAC forecasted (2018-2023) market revenue (USD Bn) 17. APAC historical (2015-2017) market volume (Million units) 18. APAC forecasted (2018-2023) market volume (Million units) 19. LATAM historical (2015-2017) market revenue (USD Bn) 20. LATAM forecasted (2018-2023) market revenue (USD Bn) 21. LATAM historical (2015-2017) market volume (Million units) 22. LATAM forecasted (2018-2023) market volume (Million units) 23. MEA historical (2015-2017) market revenue (USD Bn) 24. MEA forecasted (2018-2023) market revenue (USD Bn) 25. MEA historical (2015-2017) market volume (Million units) 26. MEA forecasted (2018-2023) market volume (Million units) 27. Value chain Chapter 3: 1. Pneumococcal – (2015, 2018, 2023) global revenue(USD Bn) 2. Pneumococcal – (2015, 2018, 2023) global volume (Million units) 3. Hib – (2015, 2018, 2023) global revenue(USD Bn) 4. Hib – (2015, 2018, 2023) global volume (Million units) 5. DTP – (2015, 2018, 2023) global revenue(USD Bn) 6. DTP – (2015, 2018, 2023) global volume (Million units) 7. Meningococcal – (2015, 2018, 2023) global revenue(USD Bn) 8. Meningococcal – (2015, 2018, 2023) global volume (Million units) Chapter 4: 1. Paediatric – (2015, 2018, 2023) global revenue(USD Bn) 2. Paediatric – (2015, 2018, 2023) global volume(Million units) 3. Adult – (2015, 2018, 2023) global revenue(USD Bn) 4. Adult – (2015, 2018, 2023) global revenue(Million units) Chapter 5, 7, 9, 11, 13: 1. Pneumococcal conjugate vaccine market –(2015, 2018, 2023) by revenue (USD Bn) 2. Pneumococcal conjugate vaccine market –(2015, 2018, 2023) by volume (Million units) 3. Haemophilus Influenza Type b conjugate vaccine market -(2015, 2018, 2023) by revenue (USD Bn) 4. Haemophilus Influenza Type b conjugate vaccine market -(2015, 2018, 2023) by volume (Million units) 5. Diphtheria-Tetanus-Pertussis conjugate vaccine market -(2015, 2018, 2023) by revenue (USD Bn) 6. Diphtheria-Tetanus-Pertussis conjugate vaccine market -(2015, 2018, 2023) by volume (Million units) 7. Meningococcal conjugate vaccine market -(2015, 2018, 2023) by revenue (USD Bn) 8. Meningococcal conjugate vaccine market -(2015, 2018, 2023) by volume (Million units) Chapter 6, 8, 10, 12, 14: 1. Pediatric vaccine market -(2015, 2018, 2023) by revenue (USD Bn) 2. Pediatric vaccine market -(2015, 2018, 2023) by volume (Million units) 3. Adult vaccine market -(2015, 2018, 2023) by revenue (USD Bn) 4. Adult vaccine market -(2015, 2018, 2023) by volume (Million units) Chapter 15: 1. Top 5 companiesTable 1: Global segment by disease indication (2015 – 2023) value in USD Bn Table 2: Global segment by disease indication (2015 – 2023) volume in Million units Table 3: Global segment by end user (2015 – 2023) value in USD Bn Table 4: Global segment by end user (2015 – 2023) value in Million units Table 5: Segment by geography (2015 – 2023) value in USD Bn Table 6: Segment by geography (2015 – 2023) volume in Million units Table 7: North America - segment by disease indication (2015 – 2023) value in USD Bn Table 8: North America - segment by end user (2015 – 2023) value in USD Bn Table 9: North America - segment by disease indication (2015 – 2023) volume in Million units Table 10: North America - segment by end user (2015 – 2023) volume in Million units Table 11: Europe - segment by disease indication (2015 – 2023) value in USD Bn Table 12: Europe - segment by end user (2015 – 2023) value in USD Bn Table 13: Europe - segment by disease indication (2015 – 2023) volume in Million units Table 14: Europe - segment by end user (2015 – 2023) volume in Million units Table 15: APAC - segment by disease indication (2015 – 2023) value in USD Bn Table 16: APAC - segment by end user (2015 – 2023) value in USD Bn Table 17: APAC - segment by disease indication (2015 – 2023) volume in Million units Table 18: APAC - segment by end user (2015 – 2023) volume in Million units Table 19: LATAM - segment by disease indication (2015 – 2023) value in USD Bn Table 20: LATAM - segment by end user (2015 – 2023) value in USD Bn Table 21: LATAM - segment by disease indication (2015 – 2023) volume in Million units Table 22: LATAM - segment by end user (2015 – 2023) volume in Million units Table 23: MEA - segment by disease indication (2015 – 2023) value in USD Bn Table 24: MEA - segment by end user (2015 – 2023) value in USD Bn Table 25: MEA - segment by disease indication (2015 – 2023) volume in Million units Table 26: MEA - segment by end user (2015 – 2023) volume in Million units Table 27: Population aged 80 years or over for the world, regions and income groups, 2000, 2015, 2030 And 2050 Table 28: Percentage of the population of older age group (aged 65 and above) by country: 1950, 1980, 2015, and 2050 (Est.) Table 28(Contd.): Percentage of the population of older age group (aged 65 and above) by country: 1950, 1980, 2015, and 2050 (Est.)

o GlaxoSmithKline o Pfizer Inc. o Merck & Co. o Novartis o Sanofi Pasteur o CSL Limited o Bharat Biotech International o Biological E Limited o Serum Institute of India